选择气道专业的亲解决调解者与非病毒性COPD恶化复苏有关
Lydia J Finney1, Jordina Mah2, Melody Duvall3
1Imperial College London National Heart and Lung Institute, Respiratory Medicine, London, United Kingdom of Great Britain and Northern Ireland; l.finney@imperial.ac.uk.
概括
在慢性阻塞性肺病 (COPD) 恶化期间,专门的亲解决媒介 (SPMs) 发生变化. 较低的Resolvin D1 (RvD1) 水平与更长的恢复相关,这表明RvD1是COPD患者的潜在治疗方法.
科学领域:
- 肺病学和呼吸系统医学
- 免疫学和炎症研究研究
- 药理学和治疗学 药理学和治疗学
背景情况:
- 慢性阻塞性肺病 (COPD) 恶化有不同的恢复模式,影响疾病的进展.
- 呼吸道炎症的解决是一个活跃的过程,可能由专门的解决媒介 (SPMs) 调解.
研究的目的:
- 调查COPD患者在恶化期间的唾液中SPM的时间动态.
- 将SPM水平与恶化触发因素和恢复时间表联系起来.
- 探索SPM在COPD恶化的解决过程中的作用.
主要方法:
- 对COPD患者的长度研究 (伦敦COPD恶化队列,2016-2018) 在恶化恢复期间定期评估.
- 唾液,呼吸道样本,血液和精神测量在基线,发病和发病后1,2,6周收集.
- 在唾液中使用液态染色学-并联质谱学量化SPM;通过PCR和培养物确定病毒和细菌触发物.
主要成果:
- 在非病毒性 (13天) 与病毒性 (21天) 恶化中,症状恢复速度更快.
- 在细菌,但不是病毒病例中,在恶化开始时,Resolvin D1 (RvD1) 增加.
- 在发病1周和2周后降低RvD1水平与延长的呼吸道症状相关;外源RvD1在体外减少了炎症反应.
结论:
- 在COPD恶化期间,气道SPM水平呈现出动态变化.
- 减少RvD1度与症状持续时间的延长有关.
- SPM,特别是RvD1,代表了增强COPD恶化恢复的有希望的治疗目标.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
334
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
334
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:29Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
01:20COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223